eMedica line of treatment for parkinsons
Nerve cells, also known as neurons, are specialized cells that form the nervous system. They transmit electrical and chemical signals, enabling us to sense and react to our surroundings. Deep Brain Stimulation (DBS) can assist individuals with advanced Parkinson's disease who do not adequately respond to medication alone. DBS involves using electrical impulses to manage motor symptoms like tremors, rigidity, and bradykinesia.
Parkinson's disease is a neurodegenerative disorder characterized by the impairment of nerve cells, or neurons, in the brain. These cells play a crucial role in transmitting electrical and chemical signals that enable proper motor function. Deep Brain Stimulation (DBS) has emerged as a viable treatment option for individuals with advanced Parkinson's who do not respond adequately to medication alone. In this article, we delve into the scientific principles underlying electron-driven cell therapy, facilitated by the eMedica device, and its potential benefits in managing Parkinson's symptoms.
eMedica
Works on three dimensions of healing Voltages, Frequencies & Current Ethical Papers & Clinical Reports Attached to the link https://lnkd.in/dCVrUhUy
Electron-Driven Cell Therapy for Parkinson’s: The eMedica device harnesses the power of precise frequencies and microcurrents to deliver electron-driven cell therapy for Parkinson's treatment. By employing specific voltages and frequencies, this therapy aims to enhance the functionality and potency of nerve cells, providing a potential avenue for improving motor symptoms and overall quality of life.
Fat Deposits Dissolution and Nerve Cell Activation: Microcurrent therapy administered through the eMedica device has been proposed to assist in burning fat deposits on the walls of nerves. This process may contribute to the energization of nerve cells, potentially enhancing their functionality and optimizing signal transmission. By addressing the presence of fat deposits and promoting nerve cell activation, electron-driven cell therapy may offer benefits in managing Parkinson's symptoms.
Enhanced Dopamine Circuit and Motor Control: The eMedica device aims to enhance cell potency by charging nerve cells with specific voltages and frequencies. This targeted approach seeks to excite the striatum of the substantia nigra, a key brain region involved in motor control. By sending inhibitory impulses to GABAergic neurons, electron-driven cell therapy may assist in regulating involuntary movements associated with Parkinson's. Additionally, the optimization of the dopamine circuit through this therapy holds the potential for improving motor function and reducing symptom severity.
Deep Brain Stimulation and Treatment Efficacy: Deep Brain Stimulation (DBS) has demonstrated effectiveness in managing advanced Parkinson's symptoms. By delivering electrical impulses to specific brain regions, DBS modulates neural activity and helps alleviate motor symptoms such as tremors, rigidity, and bradykinesia. Electron-driven cell therapy, as facilitated by the eMedica device, offers a non-invasive alternative to traditional surgical DBS, potentially providing comparable benefits with fewer associated risks.
Conclusion: Electron-driven cell therapy, administered through the eMedica device, presents a promising approach to advancing the treatment of Parkinson's disease. By targeting fat deposits on nerve cell walls and utilizing specific voltages and frequencies, this therapy aims to enhance nerve cell potency and optimize motor control pathways.